These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25862821)

  • 1. T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.
    Reynolds C; Goudet A; Jenjaroen K; Sumonwiriya M; Rinchai D; Musson J; Overbeek S; Makinde J; Quigley K; Manji J; Spink N; Yos P; Wuthiekanun V; Bancroft G; Robinson J; Lertmemongkolchai G; Dunachie S; Maillere B; Holden M; Altmann D; Boyton R
    J Immunol; 2015 May; 194(10):4814-24. PubMed ID: 25862821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.
    Musson JA; Reynolds CJ; Rinchai D; Nithichanon A; Khaenam P; Favry E; Spink N; Chu KK; De Soyza A; Bancroft GJ; Lertmemongkolchai G; Maillere B; Boyton RJ; Altmann DM; Robinson JH
    J Immunol; 2014 Dec; 193(12):6041-9. PubMed ID: 25392525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
    Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
    J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.
    Chu KK; Tippayawat P; Walker NJ; Harding SV; Atkins HS; Maillere B; Bancroft GJ; Lertmemongkolchai G; Altmann DM
    Eur J Immunol; 2011 Jan; 41(1):107-15. PubMed ID: 21182082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse vaccinology and subtractive genomics-based putative vaccine targets identification for Burkholderia pseudomallei Bp1651.
    Hizbullah ; Nazir Z; Afridi SG; Shah M; Shams S; Khan A
    Microb Pathog; 2018 Dec; 125():219-229. PubMed ID: 30243554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Control of
    Nithichanon A; Rinchai D; Buddhisa S; Saenmuang P; Kewcharoenwong C; Kessler B; Khaenam P; Chetchotisakd P; Maillere B; Robinson J; Reynolds CJ; Boyton RJ; Altmann DM; Lertmemongkolchai G
    Front Immunol; 2018; 9():484. PubMed ID: 29616023
    [No Abstract]   [Full Text] [Related]  

  • 7. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Melioidosis Subunit Vaccines Using an Enzymatically Inactive Burkholderia pseudomallei AhpC.
    Schmidt LK; Orne CE; Shaffer TL; Wilson SM; Khakhum N; Torres AG; Brett PJ; Burtnick MN
    Infect Immun; 2022 Aug; 90(8):e0022222. PubMed ID: 35862715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection with Burkholderia pseudomallei - immune correlates of survival in acute melioidosis.
    Dunachie SJ; Jenjaroen K; Reynolds CJ; Quigley KJ; Sergeant R; Sumonwiriya M; Chaichana P; Chumseng S; Ariyaprasert P; Lassaux P; Gourlay L; Promwong C; Teparrukkul P; Limmathurotsakul D; Day NPJ; Altmann DM; Boyton RJ
    Sci Rep; 2017 Sep; 7(1):12143. PubMed ID: 28939855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.
    Tomás-Cortázar J; Bossi L; Quinn C; Reynolds CJ; Butler DK; Corcoran N; Murchú MÓ; McMahon E; Singh M; Rongkard P; Anguita J; Blanco A; Dunachie SJ; Altmann D; Boyton RJ; Arnold J; Giltaire S; McClean S
    Front Immunol; 2021; 12():767359. PubMed ID: 34966388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.
    Tippayawat P; Pinsiri M; Rinchai D; Riyapa D; Romphruk A; Gan YH; Houghton RL; Felgner PL; Titball RW; Stevens MP; Galyov EE; Bancroft GJ; Lertmemongkolchai G
    Infect Immun; 2011 Jan; 79(1):305-13. PubMed ID: 21041491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity.
    Lazzaroni SM; Barnes JL; Williams NL; Govan BL; Norton RE; LaBrooy JT; Ketheesan N
    Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S66-70. PubMed ID: 19121692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.
    Healey GD; Elvin SJ; Morton M; Williamson ED
    Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis.
    Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS
    Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.
    Tippayawat P; Saenwongsa W; Mahawantung J; Suwannasaen D; Chetchotisakd P; Limmathurotsakul D; Peacock SJ; Felgner PL; Atkins HS; Titball RW; Bancroft GJ; Lertmemongkolchai G
    PLoS Negl Trop Dis; 2009; 3(4):e407. PubMed ID: 19352426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melioidosis Patient Survival Correlates With Strong IFN-γ Secreting T Cell Responses Against Hcp1 and TssM.
    Sengyee S; Yarasai A; Janon R; Morakot C; Ottiwet O; Schmidt LK; West TE; Burtnick MN; Chantratita N; Brett PJ
    Front Immunol; 2021; 12():698303. PubMed ID: 34394091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
    Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
    Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses.
    See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of protective immunity in a murine model of melioidosis is influenced by the source of Burkholderia pseudomallei antigens.
    Barnes JL; Ketheesan N
    Immunol Cell Biol; 2007 Oct; 85(7):551-7. PubMed ID: 17563759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.